The path to weight loss is also guided by hormones, metabolism, and genetics
GLP-1 prescription growth reflects FDA approvals of newer, more effective agents like semaglutide and tirzepatide, demonstrated cardiovascular benefits in clinical trials, and expanded indications for both type 2 diabetes and chronic weight management
Dont hesitate to contact your healthcare provider or use telehealth services if you experience side effects
Publication Details Paper Title: Risk of hair loss associated with glucagon-like peptide-1 receptor agonists in adults with type 2 diabetes: target trial emulation | Authors: Huilin Tang, Bingyu Zhang, Yiwen Lu, Dazheng Zhang, Ruishan Liu, Yuan Lu, George Cotsarelis, David A
Sometimes an antidepressant if indicated, chosen carefully to avoid metabolic side effects
Ahead, Dr